Back

Aspirin Discontinuation 1-month After PCI in Acute Myocardial Infarction: Individual-patient-data pooled analysis of the TARGET-FIRST and ULTIMATE-DAPT randomized trials

29 August 2026 (14:45 - 15:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: optimising management of acute myocardial infarction Antiplatelet Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Giuseppe Tarantini

University of Padua, Padova (Italy)

4 More presentations in this session

Presentation thumbnail
EnVast thrombectomy device as adjunctive reperfusion modality in ST-segment elevation myocardial infarction
Professor M. Valgimigli (Lugano, CH)
Slides Video
Presentation thumbnail
Time-dependent effects of physiology-guided staged complete revascularisation in ST-segment elevation myocardial infarction with MVD disease: a multicentre, open -labelled, randomised STAGED trial
Professor Y. Wang (Xiamen, CN)
Slides Video
Presentation thumbnail
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk: Evidence from the SELUTION DeNovo trial
Professor T. Rissanen (Joensuu, FI)
Slides Video
Presentation thumbnail
Immediate Versus Deferred Percutaneous Coronary Intervention in Clinically Stable Patients with STEMI Presenting Beyond 12 Hours of Symptom Onset - The LATE-MI Randomized Trial
Doctor L. Nepper-Christensen (Copenhagen, DK)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: optimising management of acute myocardial infarction
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 14:45 CET
You may be interested in
thumbnail
Congress Session
HOT LINE 7
31 August 2025
thumbnail
Congress Presentation
PREMIUM: Aspirin Omission at the Time of Primary PCI in STEMI
29 August 2026
thumbnail
Congress Presentation
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials
31 August 2024
thumbnail
Congress Presentation
Discussant review - TARGET-FIRST
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources